Skip to main content
HR 6478 115th Congress House

Biosimilars Competition Act of 2018

Official title: To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust… Show full official titleShow less

Official title: To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.

Introduced: July 23, 2018 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 27, 2018
Referred to the Subcommittee on Health.
Jul 23, 2018
Referred to the House Committee on Energy and Commerce.
Jul 23, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 27, 2018

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6478: Biosimilars Competition Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-6478/
MLA
"H.R. 6478: Biosimilars Competition Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-6478/.
Bluebook (legal)
H.R. 6478, 115th Cong. (2026), https://openamerica.io/bill/115-HR-6478/.
Markdown link
[H.R. 6478: Biosimilars Competition Act of 2018](https://openamerica.io/bill/115-HR-6478/)
Report a problem